Advertising exemption: Aspro protect
THERAPEUTIC GOODS ACT 1989
I, PIO CESARIN, Director, Non-Prescription Medicines Branch, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing for the purposes of section 42 DK (1) of the Therapeutic Goods Act, give notice that the restricted representations described in paragraph (a) below, being representations that are necessary for the appropriate use of the therapeutic goods described in paragraph (b) below, may be included either on the label of the package of those goods or in information included in the package in which those goods are contained:
- representations to the effect that the goods described in paragraph (b) below may be used to "reduce the risk of heart attack and stroke by helping to prevent blood clotting in patients with known cardiovascular or cerebrovascular disease" or to "reduce the risk of heart attack, stroke, unstable angina and transient ischaemic attack (TIA) by helping to prevent blood clotting in patients with known cardiovascular or cerebrovascular disease".
- ASPRO PROTECT 100mg aspirin enteric coated tablet blister pack
- supplied as an over-the-counter drug by Bayer Australia Limited.
Dated this 14th day of March 2008.
Pio Cesarin
Delegate of the Secretary to the Department of Health and Ageing